IP Library › Granted Patent US 11,175,585
Granted Patent B2
US 11,175,585 · App. 16/172,027 · Granted Nov 16, 2021

Treatment liquid and treatment liquid housing body

Inventors: Satoru Murayama (Haibara-gun, JP); Tetsuya Shimizu (Haibara-gun, JP); Tetsuya Kamimura (Haibara-gun, JP)
Assignee: FUJIFILM Corporation
G03F7/322G03F7/0397G03F7/325G03F7/40H01L21/0271H01L21/0274
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,175,585
App. No.
16/172,027
Granted
Nov 16, 2021
Kind
B2
Abstract

An object of the present invention is to provide a treatment liquid which is capable of suppressing the generation of defects of a semiconductor device and has excellent corrosion resistance and wettability. The treatment liquid of the present invention is a treatment liquid for a semiconductor device, containing at least one organic solvent selected from the group consisting of ethers, ketones, and lactones, water, and a metal component including at least one metal element selected from the group consisting of Na, K, Ca, Fe, Cu, Mg, Mn, Li, Al, Cr, Ni, Ti, and Zn, in which the content of water in the treatment liquid is 100 ppb by mass to 100 ppm by mass and the content of the metal component in the treatment liquid is 10 ppq by mass to 10 ppb by mass.

Claims (43)

1. A treatment liquid for a semiconductor device, comprising:

at least one organic solvent selected from the group consisting of ethers, ketones, and lactones;

water; and

a metal component including at least one metal element selected from the group consisting of Na, K, Ca, Fe, Cu, Mg, Mn, Li, Al, Cr, Ni, Ti, and Zn,

wherein the content of the water in the treatment liquid is 100 ppb by mass to 100 ppm by mass,

the content of the metal component in the treatment liquid is 10 ppq by mass to 10 ppb by mass, and

the treatment liquid satisfies at least one of the following conditions (A) and (B):

condition (A): the organic solvent includes ethers, and the treatment liquid further includes alkenes, wherein the content of the alkenes in the treatment liquid is 0.1 ppb by mass to 100 ppb by mass,

condition (B): the organic solvent includes lactones, and the treatment liquid further includes at least one acid component selected from an inorganic acid or an organic acid, wherein the content of the acid component in the treatment liquid is 0.1 ppb by mass to 100 ppb by mass.

2. The treatment liquid according to claim 1 ,

wherein the metal component includes a particulate metal component, and

the content of the particulate metal component in the treatment liquid is 1 ppq by mass to 1 ppb by mass.

3. The treatment liquid according to claim 2 , which is used in at least one of a rinsing liquid or a pre-wet liquid.

4. The treatment liquid according to claim 3 ,

wherein the ethers are at least one selected from the group consisting of diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, and propylene glycol monopropyl ether acetate.

5. The treatment liquid according to claim 2 ,

wherein the ethers are at least one selected from the group consisting of diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, and propylene glycol monopropyl ether acetate.

6. The treatment liquid according to claim 2 ,

wherein the ketones are at least one selected from the group consisting of methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 4-heptanone, N-methyl-2-pyrrolidone, methyl propyl ketone, methyl-n-butyl ketone, and methyl isobutyl ketone.

7. The treatment liquid according to claim 1 , which is used in at least one of a rinsing liquid or a pre-wet liquid.

8. The treatment liquid according to claim 7 ,

wherein the ethers are at least one selected from the group consisting of diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, and propylene glycol monopropyl ether acetate.

9. The treatment liquid according to claim 7 ,

wherein the ketones are at least one selected from the group consisting of methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 4-heptanone, N-methyl-2-pyrrolidone, methyl propyl ketone, methyl-n-butyl ketone, and methyl isobutyl ketone.

10. The treatment liquid according to claim 1 ,

wherein the ethers are at least one selected from the group consisting of diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, and propylene glycol monopropyl ether acetate.

11. The treatment liquid according to claim 10 ,

wherein the ketones are at least one selected from the group consisting of methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 4-heptanone, N-methyl-2-pyrrolidone, methyl propyl ketone, methyl-n-butyl ketone, and methyl isobutyl ketone.

12. The treatment liquid according to claim 1 ,

wherein the ketones are at least one selected from the group consisting of methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 4-heptanone, N-methyl-2-pyrrolidone, methyl propyl ketone, methyl-n-butyl ketone, and methyl isobutyl ketone.

13. The treatment liquid according to claim 1 ,

wherein the lactones are at least one selected from the group consisting of β-propiolactone, γ-butyrolactone, γ-valerolactone, δ-valerolactone, γ-caprolactone, and ε-caprolactone.

14. The treatment liquid according to claim 1 ,

wherein the content of the water in the treatment liquid is 100 ppb by mass to 10 ppm by mass.

15. The treatment liquid according to claim 1 ,

wherein the content of the water in the treatment liquid is 100 ppb by mass to 1 ppm by mass.

16. The treatment liquid according to claim 1 ,

wherein the organic solvent includes at least ethers.

17. A treatment liquid housing body comprising:

a container; and

the treatment liquid according to claim 1 housed in the container.

18. The treatment liquid housing body according to claim 17 ,

wherein the inner wall of the container is formed of at least one material selected from a fluorine-based resin, quartz, or an electropolished metal material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2018
From: MURAYAMA, SATORU; SHIMIZU, TETSUYA; KAMIMURA, TETSUYA
To: FUJIFILM CORPORATION
Reel/Frame 047329/0042 →
Priority Claims (2)
JP JP2016-092057 · Apr 28, 2016 · national
JP JP2017-084479 · Apr 21, 2017 · national
Continuity (2)
Continuation PCTJP2017016479 · Apr 26, 2017
Related Publication 20190064672A1 · Feb 28, 2019
Cited By (3)
US 12,436,461 US 12,509,598 US 12,525,445